Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
7
Page:
99-109
Author(s):
G. Gross and A. Margalit
The Anti-Cancer Charm of Flavonoids: A Cup-of-Tea Will Do!
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
109-117
Author(s):
Amr Amin and Michael Buratovich
Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
119-134
Author(s):
Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, Monia Rocco, Giuseppe Manzo and Michele Caraglia
Mechanisms to Inhibit Matrix Metalloproteinase Activity: Where are we in the Development of Clinically Relevant Inhibitors?
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
135-142
Author(s):
Christian A. Corbitt, Jing Lin and Merry L. Lindsey
Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
143-158
Author(s):
Andrew R. Hsu, Anand Veeravagu, Weibo Cai, Lewis C. Hou, Victor Tse and Xiaoyuan Chen
Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
159-166
Author(s):
Barbara J. Kelly, Marina N. Fleeton and Gregory J. Atkins
Thalidomide Analogues as Anticancer Drugs
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
167-174
Author(s):
Jeanny B. Aragon-Ching, Haiqing Li, Erin R. Gardner and William D. Figg
Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
175-186
Author(s):
Constantinos Mikelis, Marina Koutsioumpa and Evangelia Papadimitriou
Regulators of the G1 Phase of the Cell Cycle and Neurogenesis
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
7
Page:
115-128
Author(s):
Maryline Paris and Ourania M. Andrisani
Genetics and Genomics of Hepatic Acute Phase Reactants: A Mini-Review
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
6
Page:
109-115
Author(s):
Andras K. Fulop